- Latest available (Revised)
- Point in Time (06/01/2006)
- Original (As made)
Version Superseded: 01/05/2006
Point in time view as at 06/01/2006.
There are currently no known outstanding effects for the The Prescription Only Medicines (Human Use) Order 1997, SCHEDULE 3A.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Article 3A
Textual Amendments
F1Sch. 3A inserted (1.4.2002) by The Prescription Only Medicines (Human Use) Amendment Order 2002 (S.I. 2002/549), arts. 1(1), 9
Column 1 | Column 2 |
---|---|
Substance | Requirements as to use, route of administration, or pharmaceutical form |
[F2Acetylcysteine | Parenteral] |
Aciclovir | External use |
Acrivastine | Oral |
Adapalene | External use |
[F2Adrenaline | Parenteral] |
Alclometasone dipropionate | External use |
Alimemazine tartrate (trimeprazine tartrate) | Oral |
[F2Alteplase | Parenteral] |
[F2Amiodarone | Parenteral] |
[F3Amitriptyline hydrochloride | Oral [F4administration in palliative care]] |
Amorolfine hydrochloride | External use |
Amoxycillin trihydrate | Oral |
Aspirin | Oral |
Azelaic acid | External use |
Azelastine hydrochloride | Ophthalmic use or nasal |
[F3Azithromycin dihydrate | Oral] |
Baclofen | Oral administration in palliative care |
Beclometasone dipropionate | External use or nasal [F5inhalation] |
[F2Bemiparin sodium | Parenteral] |
[F2Benzatropine mesilate | Parenteral] |
[F6Benzylpenicillin sodium | Parenteral] |
Betamethasone dipropionate | External use |
Betamethasone sodium phosphate | Aural or nasal |
Betamethasone valerate | External use |
Budesonide | Nasal [F7inhalation] |
[F8Buprenorphine | Transdermal administration in palliative care] |
[F2Calcipotriol | External] |
[F2Calcitriol | External] |
[F3Carbamazepine | Oral or rectal [F9administration in palliative care]] |
Carbaryl | External use |
Carbenoxolone sodium | Mouthwash |
[F2Cefotaxime sodium | Parenteral] |
[F2Ceftriaxone Sodium | Parenteral] |
[F2Certoparin sodium | Parenteral] |
Cetirizine hydrochloride | Oral |
[F2Chlorphenamine maleate | Parenteral] |
Chloramphenicol | Ophthalmic use |
[F8Chlordiazepoxide hydrochloride | Oral] |
Cimetidine | Oral |
[F2Cimetidine | Parenteral] |
Cinchocaine hydrochloride | External use |
[F3Clavulanic acid [F10(as potassium clavulanate)] | Oral] |
Clindamycin phosphate | External use |
Clobetasone butyrate | External use |
Clotrimazole | External use |
[F11Codeine Phosphate | Oral] |
[F3Conjugated oestrogens (equine) | External use] |
[F11Co-Phenotrope | Oral] |
F12. . . | F12. . . |
[F2Cyclizine hydrochloride | Oral] |
[F2Cyclizine lactate | Parenteral] |
[F2Dalteparin sodicum | Parenteral] |
Dantrolene sodium | Oral administration in palliative care |
Dantron | Oral |
Desogestrel | Oral |
Desoximetasone (Desoxymethasone) | External use |
Dexamethasone | Aural |
Dexamethasone isonicotinate | Nasal |
[F2Dexamethasone sodium phosphate | Oral] |
[F2Dextran 70 | Parenteral] |
[F8Diamorphine hydrochloride | Oral and parenteral] |
[F11Diazepam | Oral, parenteral or rectal administration F13...] |
Diclofenac diethylammonium | External use |
[F3Diclofenac potassium | Oral] |
[F3Diclofenac sodium | Oral F14... rectal [F15or ophthalmic]] |
[F11Dihydrocodeine Tartrate | Oral] |
[F2Dolesetron mesilate | Oral and parenteral] |
Domperidone | Oral or rectal administration F16... |
Domperidone maleate | Oral administration F17... |
Doxycycline [F18hyclate] | Oral |
[F19Doxycycline monohydrate | Oral] |
Econazole nitrate | External use |
[F19Emedastine | Ophthalmic use] |
[F2Enoxaparin | Parenteral] |
Erythromycin | External use [F20or oral] |
[F3Erythromycin ethyl succinate | Oral] |
[F3Erythromycin stearate | Oral] |
[F3Estradiol | External use] |
[F3Estriol | External use] |
Ethinylestradiol | Oral |
[F3Etonogestrel | Implant] |
Etynodiol diacetate (ethynodiol diacetate) | Oral |
Famotidine | Oral |
Felbinac | External use |
Fenticonazole nitrate | External use |
[F8Fentanyl | Transdermal administration in palliative care] |
Fexofenadine hydrochloride | Oral |
[F19Flucloxacillin magnesium | Oral] |
Flucloxacillin sodium | Oral [F21or parenteral] |
Fluconazole | Oral |
Fludroxycortide (Flurandrenolone) | External use |
[F3Flumazenil | Parenteral] |
Flumetasone pivalate | Aural |
Flunisolide | Nasal |
Fluocinolone acetonide | External use |
Fluocinonide | External use |
Fluocortolone hexanoate | External use |
Fluocortolone pivalate | External use |
Flurbiprofen | Lozenges |
Fluticasone propionate | External use or nasal |
[F2Furosemide | Oral and parenteral] |
Fusidic acid | [F22External Use] |
[F3Gabapentin | Oral [F23administration in palliative care]] |
[F2Gelatin 3.5 – 4% | Parenteral] |
Gentamicin sulphate | Aural |
Gestodene | Oral |
[F3Glucagon hydrochloride | Parenteral] |
[F3Glucose | Parenteral] |
[F2Glucose 5% | Parenteral] |
[F2Glucose 5% with Potassium (K+ 40 mmol/L) ready made infusion bag | Parenteral] |
[F2Granisetron hydrochloride | Parenteral] |
[F2Heparin sodium | Parenteral for the purpose of cannulae flushing] |
[F2Hexastarch | Parenteral] |
[F2Human soluble insulin | Parenteral] |
Hydrocortisone | External use |
Hydrocortisone acetate | External use [F24or aural] |
Hydrocortisone butyrate | External use |
Hydrocortisone sodium succinate | Lozenges [F25or parenteral] |
[F2Hydroxyethl starch | Parenteral] |
[F26Hyoscine | Transdermal administration in palliative care] |
Hyoscine butylbromide | Parenteral F27... administration in palliative care |
Hyoscine hydrobromide | [F28Oral or parenteral administration in palliative care] |
Ibuprofen | External use or oral |
Ibuprofen lysine | Oral |
[F3Imipramine hydrochloride | Oral [F29administration in palliative care]] |
Ipratropium bromide | Nasal [F30inhalation] |
Isotretinoin | External use |
Ketoconazole | External use |
Ketoprofen | External use |
Levocabastine hydrochloride | Ophthalmic use or nasal |
[F2Levomepromazine | Oral and parenteral] |
F31. . . | F31. . . |
F31. . . | F31. . . |
Levonorgestrel | Oral |
[F3Lignocaine hydrochloride | External use or parenteral] |
Lithium succinate | External use |
Lodoxamide trometamol | Ophthalmic use |
Loperamide hydrochloride | Oral |
Loratadine | Oral |
[F11Lorazepam | Oral or parenteral administration F32...] |
[F3Lymecycline | Oral] |
Mebendazole | Oral |
Medroxyprogesterone acetate | Parenteral |
Mestranol | Oral |
Metoclopramide hydrochloride | Oral or parenteral administration F33... |
Metronidazole | [F34External use, oral or rectal] |
Metronidazole benzoate | Oral |
Miconazole | Dental lacquer |
Miconazole nitrate | External use |
[F11Midazolam | Parenteral administration F35...] |
Minocycline | Oral |
[F19Mizolastine | Oral] |
[F19Minocycline hydrochloride | Oral] |
Mometasone furoate | External use or nasal |
[F8Morphine hydrochloride | Rectal] |
[F8Morphine sulphate | Oral, parenteral and rectal] |
[F2Naloxone | Parenteral] |
Nedocromil sodium | Ophthalmic use |
Nefopam hydrochloride | Oral |
Neomycin sulphate | Aural |
Neomycin undecenoate | Aural |
Nitrofurantoin | Oral |
Nizatidine | Oral |
Norethisterone 9 | Oral |
Norethisterone acetate | Oral |
Norethisterone enanthate | Parenteral |
Norgestimate | Oral |
Norgestrel | Oral |
[F3Nortriptyline hydrochloride | Oral [F36administration in palliative care]] |
Nystatin | External use |
[F2Omeprazole | Oral] |
[F2Omeprazole sodium | Parenteral] |
[F2Ondansetron Hydrochloride | Oral and parenteral] |
[F2Oxbuprocaine hydrochloride | Ophalmic] |
[F8Oxycodone hydrochloride | Oral and parenteral administration in palliative care] |
Oxytetracycline dihydrate | Oral |
Paracetamol | Oral |
Penciclovir | External use |
[F2Pentastarch | Parenteral] |
Piroxicam | External use |
[F3Prednisolone | Oral] |
Prednisolone hexanoate | External use |
Prednisolone sodium phosphate | Aural [F37or oral] |
[F2Prilocaine | External and parenteral] |
[F2Prochlorperazine maleate | Oral, rectal and buccal] |
[F2Prochlorperazine mesilate | Oral and rectal] |
[F2Proxymetacaine hydrochloride | Ophthalmic] |
Ranitidine hydrochloride | Oral [F38or parenteral] |
[F2Reteplase | Parenteral] |
[F3Salbutamol sulphate | Inhalation] |
Silver sulphadiazine | External use |
[F2Sodium chloride 0.9% | Parental, for reconstitution of injections and for the purpose of cannulae flushing] |
[F2Sodium chloride 0.9% & Glucose 5% ready made infusion bag | Parenteral] |
[F2Sodium chloride 0.45% & Glucose 5% ready made infusion bag ] | |
[F2Sodium chloride 0.9% with Potassium (K+ 40 mmol/L) ready made infusion bag | Parenteral] |
[F2Sodium chloride 0.45% and Glucose 5% with Potassium 20mmol per 500 ml ready made infusion bag | Parenteral] |
Sodium cromoglycate | Ophthalmic use |
[F3Sodium fusidate | External use] |
Streptodornase | External use |
Streptokinase | External use |
[F2Streptokinase | Parenteral] |
Sulconazole nitrate | External use |
[F2Tacalcitol | External] |
[F2Tenecteplase | Parenteral] |
[F2Tetanus immunoglobulin | Parenteral] |
Terbinafine hydrochloride | External use |
[F3Terbutaline sulphate | Inhalation] |
[F2Tetracaine | External] |
Tetracycline hydrochloride | External use or oral |
[F2Tinzaparin sodium | Parenteral] |
Tretinoin | External use |
Triamcinolone acetonide | External use, aural, nasal or oral paste |
Trimethoprim | Oral |
[F2Tropicamide | Ophthalmic] |
[F2Tropisetron hydrochloride | Parenteral] |
Tuberculin PPD | Parenteral |
[F2Unfractionated Heparin | Parenteral] |
Vaccine, Adsorbed Diphtheria | Parenteral |
Vaccine, Adsorbed Diphtheria And Tetanus | Parenteral |
Vaccine, Adsorbed Diphtheria And Tetanus For Adults And Adolescents | Parenteral |
Vaccine, Adsorbed Diphtheria For Adults And Adolescents | Parenteral |
Vaccine, Adsorbed Diphtheria, Tetanus And Pertussis | Parenteral |
Vaccine, Adsorbed Diphtheria, Tetanus And Pertussis (Acellular Component) | Parenteral |
Vaccine, BCG | Parenteral |
Vaccine, BCG Percutaneous | Parenteral |
[F2Vaccine – Combined Tetanus, diphtheria, [F39acellular pertussis], inactivated poliomyelitis and haemophilus influenza type B | Parenteral] |
Vaccine, Haemophilus Influenzae Type B (Hib) | Parenteral |
Vaccine, Haemophilus Influenzae Type B (Hib) with Diphtheria, Tetanus And Pertussis | Parenteral |
Vaccine, Haemophilus Influenzae Type B, Diphtheria, Tetanus And Acellular Pertussis | Parenteral |
Vaccine, Hepatitis A | Parenteral |
Vaccine, Hepatitis A With Typhoid | Parenteral |
Vaccine, Hepatitis A, Inactivated, With Recombinant (DNA) Hepatitis B | Parenteral |
Vaccine, Hepatitis B | Parenteral |
[F2Vaccine – Inactivated Poliomyelitis | Parenteral] |
Vaccine, Influenza | Parenteral |
Vaccine, Live Measles, Mumps And Rubella (MMR) | Parenteral |
Vaccine, Meningococcal Group C Conjugate | Parenteral |
Vaccine, Meningococcal Polysaccharide A and C | Parenteral |
[F2Vaccine – Meningococcal Polysaccharide A, C, W135 and Y | Parenteral] |
Vaccine, Pneumococcal | Parenteral |
F40. . . | F40. . . |
Vaccine, Poliomyelitis, Live (Oral) | Oral |
Vaccine, Rubella, Live | Parenteral |
Vaccine, Tetanus, Adsorbed | Parenteral |
Vaccine, Typhoid, Live Attenuated (Oral) | Oral |
Vaccine, Typhoid, Polysaccharide | Parenteral |
[F19Water for Injections | Parenteral]] |
Textual Amendments
F2Words in Sch. 3A inserted (7.4.2005) by The Medicines for Human Use (Prescribing) Order 2005 (S.I. 2005/765), arts. 1(1), 7(a)
F3Sch. 3A entries inserted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(g)
F4Words in Sch. 3A inserted (19.11.2004) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 2004 (S.I. 2004/2693), arts. 1(1), 5(a)
F5Words in Sch. 3A added (7.4.2005) by The Medicines for Human Use (Prescribing) Order 2005 (S.I. 2005/765), arts. 1(1), 7(b)
F6Words in Sch. 3A inserted (30.6.2005) by The Medicines for Human Use (Prescribing) (Miscellaneous Amendments) Order 2005 (S.I. 2005/1507), arts. 1(1), 6(a)
F7Words in Sch. 3A added (7.4.2005) by The Medicines for Human Use (Prescribing) Order 2005 (S.I. 2005/765), arts. 1(1), 7(c)
F8Words in Sch. 3A Table inserted (6.1.2006) by The Medicines for Human Use (Prescribing) (Miscellaneous Amendments) (No. 2) Order 2005 (S.I. 2005/3324), arts. 1(1), 2
F9Words in Sch. 3A inserted (19.11.2004) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 2004 (S.I. 2004/2693), arts. 1(1), 5(b)
F10Words in Sch. 3A added (18.5.2004) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2004 (S.I. 2004/1189), arts. 1(1), 3(a)
F11Words in Sch. 3A inserted (10.12.2003) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2003 (S.I. 2003/2915), arts. 1(1), 3
F12Words in Sch. 3A omitted (7.4.2005) by virtue of The Medicines for Human Use (Prescribing) Order 2005 (S.I. 2005/765), arts. 1(1), 7(d)
F13Words in Sch. 3A omitted (7.4.2005) by virtue of The Medicines for Human Use (Prescribing) Order 2005 (S.I. 2005/765), arts. 1(1), 7(e)
F14Word in Sch. 3A omitted (7.4.2005) by virtue of The Medicines for Human Use (Prescribing) Order 2005 (S.I. 2005/765), arts. 1(1), 7(f)
F15Word in Sch. 3A added (7.4.2005) by The Medicines for Human Use (Prescribing) Order 2005 (S.I. 2005/765), arts. 1(1), 7(f)
F16Words in Sch. 3A omitted (7.4.2005) by virtue of The Medicines for Human Use (Prescribing) Order 2005 (S.I. 2005/765), arts. 1(1), 7(g)
F17Words in Sch. 3A omitted (7.4.2005) by virtue of The Medicines for Human Use (Prescribing) Order 2005 (S.I. 2005/765), arts. 1(1), 7(h)
F18Words in Sch. 3A inserted (4.4.2003) by The Prescription Only Medicines (Human Use) Amendment Order 2003 (S.I. 2003/696), arts. 1(1), 15(a)
F19Words in Sch. 3A inserted (4.4.2003) by The Prescription Only Medicines (Human Use) Amendment Order 2003 (S.I. 2003/696), arts. 1(1), 15(c)
F20Words in Sch. 3A inserted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(a)
F21Words in Sch. 3A added (7.4.2005) by The Medicines for Human Use (Prescribing) Order 2005 (S.I. 2005/765), arts. 1(1), 7(i)
F22Words in Sch. 3A substituted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(b)
F23Words in Sch. 3A inserted (19.11.2004) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 2004 (S.I. 2004/2693), arts. 1(1), 5(c)
F24Words in Sch. 3A added (18.5.2004) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2004 (S.I. 2004/1189), arts. 1(1), 3(b)
F25Words in Sch. 3A added (7.4.2005) by The Medicines for Human Use (Prescribing) Order 2005 (S.I. 2005/765), arts. 1(1), 7(j)
F26Words in Sch. 3A inserted (18.5.2004) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2004 (S.I. 2004/1189), arts. 1(1), 3(d)
F27Words in Sch. 3A omitted (18.5.2004) by virtue of The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2004 (S.I. 2004/1189), arts. 1(1), 3(c)
F28Words in Sch. 3A substituted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(d)
F29Words in Sch. 3A inserted (19.11.2004) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 2004 (S.I. 2004/2693), arts. 1(1), 5(d)
F30Words in Sch. 3A added (7.4.2005) by The Medicines for Human Use (Prescribing) Order 2005 (S.I. 2005/765), arts. 1(1), 7(k)
F31Words in Sch. 3A omitted (30.6.2005) by virtue of The Medicines for Human Use (Prescribing) (Miscellaneous Amendments) Order 2005 (S.I. 2005/1507), arts. 1(1), 6(b)
F32Words in Sch. 3A omitted (7.4.2005) by virtue of The Medicines for Human Use (Prescribing) Order 2005 (S.I. 2005/765), arts. 1(1), 7(l)
F33Words in Sch. 3A omitted (7.4.2005) by virtue of The Medicines for Human Use (Prescribing) Order 2005 (S.I. 2005/765), arts. 1(1), 7(m)
F34Words in Sch. 3A substituted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(e)
F35Words in Sch. 3A omitted (7.4.2005) by virtue of The Medicines for Human Use (Prescribing) Order 2005 (S.I. 2005/765), arts. 1(1), 7(n)
F36Words in Sch. 3A inserted (19.11.2004) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 2004 (S.I. 2004/2693), arts. 1(1), 5(e)
F37Words in Sch. 3A substituted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(f)
F38Words in Sch. 3A inserted (7.4.2005) by The Medicines for Human Use (Prescribing) Order 2005 (S.I. 2005/765), arts. 1(1), 7(o)
F39Words in Sch. 3A substituted (30.6.2005) by The Medicines for Human Use (Prescribing) (Miscellaneous Amendments) Order 2005 (S.I. 2005/1507), arts. 1(1), 6(c)
F40Words in Sch. 3A omitted (4.4.2003) by virtue of The Prescription Only Medicines (Human Use) Amendment Order 2003 (S.I. 2003/696), arts. 1(1), 15(b)
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: